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Abstract 
 
Background Previous meta-analyses based on aggregate group-level data report anti-hypertensive 
effects of isometric resistance training (IRT). However, individual participant data meta-analyses 
provide more robust effect size estimates and permit examination of demographic and clinical 
variables on IRT effectiveness.   
 
Methods We conducted a systematic search and individual participant data (IPD) analysis, using both 
a one-step and two-step approach, of controlled trials investigating ≥3 weeks of IRT on resting 
systolic, diastolic and mean arterial blood pressure. 
 
Results Anonymised individual participant data were provided from 12 studies (14 intervention group 
comparisons) involving 326 participants (52.7% medicated for hypertension); 191 assigned to IRT 
and 135 controls, 25.2% of participants had diagnosed coronary artery disease. IRT intensity varied 
(8-30% MVC) and training duration ranged from 3-12 weeks. The IPD (one-step) meta-analysis 
showed a significant treatment effect for the exercise group participants experiencing a reduction in 
resting systolic blood pressure (SBP) of -6.22 mmHg (95% CI -7.75, -4.68; p<0.00001); diastolic blood 
pressure (DBP) of -2.78 mmHg (95% CI -3.92, -1.65; p=0.002); and mean arterial blood pressure 
(MAP) of -4.12 mmHg (95% CI -5.39, -2.85; p<0.00001). The two-step approach yielded similar 
results for change in SBP -7.35 mmHg (-8.95, -5.75; p<0.00001), DBP MD -3.29 mmHg (95% CI -
5.12, -1.46; p=0.0004) and MAP MD -4.63 mmHg (95% CI -6.18, -3.09: p<0.00001). Sub-analysis 
revealed that neither clinical, medication, nor demographic participant characteristics, or exercise 
program features, modified the IRT treatment effect.  
 
Conclusion This individual patient analysis confirms a clinically meaningful and statistically 
significant effect of IRT on resting systolic, diastolic and mean arterial blood pressure.  
 
Key words: hypertension, individual patient data meta-analysis, isometric exercise.  
 
BACKGROUND 
 
Hypertension, or high blood pressure, remains a leading modifiable risk factor for the development of 
cardiovascular disease, disability and death around the world 1-3.  Present guidelines recommend that 
the first line of therapy to manage high blood pressure should be the adoption of lifestyle modifications 
(e.g. increased physical activity, smoking cessation, healthy dietary habits, stress management)4-7. In 
particular, considerable evidence supports the non-pharmacological anti-hypertensive effects of 
dynamic aerobic exercise, with additional potential benefit for adjunct dynamic resistance training 8. 
Unfortunately, these types of exercises can be time consuming, limit compliance and adherence and 
may be unsuitable for patients with mobility limitations. Given that approximately 50% of people with 
hypertension do not have their blood pressure successfully controlled to within clinical targets9, 
prevention and treatment of hypertension are now global priorities of the World Health Organization10. 
Taken together, there is an urgent need to implement effective interventions to prevent or better 
manage high blood pressure. 
 
In 2013, the American Heart Association reported that there was emerging evidence supporting the 
use of isometric resistance training (IRT) for blood pressure management (Class IIB, Level of 
Evidence C) 11. This mode of exercise, performed using hand or leg dynamometry, demonstrates 
reductions in resting blood pressure in small prospective trials of normotensive and hypertensive 
participants12,13. These trials stimulated interest as IRT can be performed easily at home and requires 
a smaller investment of time from participants (approximately 12-40 minutes per week)14. The overall 
benefit of IRT has been confirmed by recent meta-analyses 8,15-18 which report systolic blood pressure 
(SBP) and diastolic blood pressure (DBP) reductions between 5-10 mmHg and 4-6 mmHg, 
respectively. This collective work contributed to the recent inclusion of IRT as a formal 
recommendation put forth by the American College of Cardiology and the American Heart Association 
in their newly released 2017 Guideline for the Prevention, Detection, Evaluation and Management of 
High Blood Pressure in Adults (listed under “Best Nonpharmacologic Interventions for Prevention and 
Treatment of Hypertension”)6. 
 
Although there is evidence to suggest a greater training response in those with higher pre-IRT blood 
pressure 19, the available data has not consistently supported overwhelmingly a larger hypotensive 
response for patients with hypertension15. In fact sub-group analysis from a meta-analysis detected 
smaller reductions in SBP, in medicated people with hypertension compared to normotensive 
participants completing IRT 15. It has been hypothesized that certain classes of anti-hypertensive 
medications may overlap with the mechanisms responsible for IRT adaptations resulting in smaller 
responses in medicated participants with hypertension 14. Unfortunately, exploring the relationships 
between reductions in resting blood pressure after IRT and baseline participant characteristics has 
not been possible with the small sample sizes of prior prospective trials or meta-analyses based on 
aggregate data. Overcoming this limitation, meta-analyses based on individual participant data (IPD) 
are considered to be more stringent in reducing bias and can improve the quality of evidence 20 21 22. 
IPD also allows associations of demographic, clinical, medicinal and IRT variables with changes in 
blood pressure to be identified. Previous meta-analyses have been unable to make these associations 
that are vital for the transition of IRT into clinical practice, however several confounding factors may 
also influence change in blood pressure including body mass23, age24 and sex25. 
 
The primary study aim was to carry out an IPD meta-analysis to examine the efficacy of IRT in 
managing resting blood pressure. The primary objective was to quantify the change in resting SBP, 
DBP, and mean arterial pressure (MAP) following >3 weeks of IRT. The secondary objective was to 
explore relationships between baseline characteristics (medication usage, age, sex, body mass index 
(BMI), and coronary artery disease (CAD) diagnosis) and the magnitude of changes in resting blood 
pressure after IRT.  
 
METHODS: 
This study was conducted and reported in accordance with current IPD guidance and the Preferred 
Reporting Items for a Systematic Review and Meta-analysis of Individual Participant Data (PRISMA 
IPD) statement26. The study was registered with PROSPERO (CRD42018109167). 
 
Search methods for identification of studies 
 
Trials for inclusion in the IRT IPD meta-analysis were identified from our recent meta-analysis 15 and 
by more recent searches of PubMed, Cochrane Central Register of Controlled Trials (CENTRAL) in 
The Cochrane Library, EMBASE, MEDLINE, CINAHL; from 1966 up until July 1, 2018. Conference 
Proceedings were searched on Web of Science. Trial registers (Controlled-trials.com and 
Clinicaltrials.gov) and reference lists of all eligible trials and identified systematic reviews were also 
checked. No language limitations were imposed. The PubMed search strategy, used for all databases, 
is available in supplementary files. We included randomized, controlled trials, but also non-
randomized, controlled trials due to the difficulty with concealment in exercise trials. With respect to 
the latter, this difficulty is known to compromise randomisation and in some previous systematic 
reviews and meta-analyses the effects of exercise have been no different when non-randomised trials 
have been included, compared to only randomised controlled trials27, moreover by including non-
randomized controlled trials we were able to maximize the data sample.  
 
Eligibility criteria for studies 
 
We included studies if they met the following inclusion and exclusion criteria: 
 Study design: We included randomized, controlled trials, but also non-randomized, controlled 
trials.  
 Population: Adult participants (18 years and older). 
 Context:  Participants training in any setting i.e. hospital, university, community facility or 
home.  
 Intervention:  Receiving an isometric resistance exercise intervention with longitudinal follow-
up before and after the intervention lasting a minimum of 3 weeks. In order to distinguish 
between acute and chronic exercise training exposure a line had to be drawn somewhere. 
During our IPD protocol development, consistent with previous work it is unlikely an IRT anti-
hypertensive effect could be observed prior to 228 or even 3 weeks19. 
 We excluded interventions without an IRT component or head-to-head comparisons of two or 
more exercise interventions, with no control group. We also excluded studies where only a 
sub-set of the total number of participants were analysed. 
 Comparator: A no-exercise group defined as no exercise or exercise at ≤5% maximal 
voluntary contractions (MVC) who carried out their usual daily activities or an attention 
placebo. 
 Sample size: We placed no restriction on sample size. 
 
Data management 
The principal investigators of included trials were invited by email to participate in this IPD meta-
analysis and share their anonymised trial data. Included datasets had ethical approval and consent 
from their sponsors. Each dataset was saved in its original format and then converted and combined 
into one overall master dataset with standardised variables. All files are stored on a secure password 
protected computer server managed in accordance with the data management standard operating 
procedures of the University of New England. Data from each trial were checked on range, extreme 
values, internal consistency, missing values, and consistency with published reports. Data 
discrepancies or missing information were discussed with trial investigators. Where errors or 
discrepancies occurred, the relevant study author was contacted and asked to check their data and 
ensure the IPD dataset tallied with the paper. There were no unresolved discrepancies. Access to 
data at all stages of cleaning and analysis was restricted to core members of the research team (NAS, 
DW and BB). 
 
Main outcomes 
 
In accordance with the study research objectives we sought IPD for the following outcomes from 
eligible trials:  
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- Resting systolic blood pressure (SBP), diastolic blood pressure (DBP) and mean arterial 
blood pressure (MAP). 
- Exercise program characteristics. 
 
We also sought individual key baseline participant demographic and clinical data (including age, 
medication and sex). Details of exercise training prescription (i.e., session frequency, duration and 
intensity and overall programme duration) were also collected as part of the review. Where available, 
we sought from investigators details, at an individual participant level, of the IRT session adherence.  
 
Collection of data 
 
Investigator contact   
 
Initially all identified trial investigative teams were emailed via the named contact author, as detailed 
in publications, to inform them about our IPD meta-analysis and to ask them if they were willing to 
share their original IPD. As part of our previous review 15 a number of investigators were contacted 
for the purposes of obtaining further data or clarification. We also attempted to identify current contact 
details of those who did not reply to initial e-mails. Positive responses were received from 12 of 18 
potential corresponding authors (See Supplementary file CONSORT statement).  
 
Data format  
 
The procedure for collection and collation of data was coordinated by the project secretariat based at 
the University of New England. Participating study authors were asked to provide de-identified primary 
datasets corresponding to minimum data required to answer the primary research objectives. Where 
possible, electronic versions of datasets were sought, together with written details of the coding of the 
variables.  
 
Data transfer and storage 
 
Methods of receiving raw data from investigators varied depending on the security concerns of their 
host institutions. However, our default approach to data transfer was either an encrypted data file sent 
via email to the project secretariat or via a password protected drop box facility. Each raw data set 
was saved in its original format and then converted and combined into one overall dataset with 
standardized variables. We worked with individual trial authors to ensure standardization of variables 
and to check that our initial analyses of individual datasets were consistent with the published results 
from the trial.  
 Data checking 
 
Data from each study was evaluated and compared with the data provided in the available publication. 
Each dataset was checked for the range of included variables to make sure none of the values were 
outliers. If any data appeared to be an outlier the original author was asked to verify. Datasets were 
also assessed for missing observations, in relation to each variable. These were checked against the 
original publication. Thereafter, an attempt was made, to replicate the results that were reported in 
the original publication, including baseline characteristics and outcome data at each available follow-
up period, by following the statistical methods as reported by the study authors. Any discrepancy or 
missing information, between our results and those presented in each original publication, was 
discussed and clarified with the original study authors. Study authors of the 6 eligible missing, datasets 
were e-mailed and if this failed they were called (telephone) directly. Our understanding is that one 
author, Wiley29, is no longer active in academia. Also due to the time elapsed since the studies were 
conducted four datasets were destroyed (Gill30, Devereux31, Miller32 and Taylor33). The other author 
Pagonas34  refused to participate. Once data checks were complete and satisfactory, individual study 
datasets were combined to form a new master dataset with a variable added to indicate the original 
study. Data from individual datasets remain the property of the collaborators who provided the data. 
 
Statistical analysis 
 
Analyses were conducted in accordance with current recommendations for IPD meta-analyses 22. A 
detailed statistical analysis plan was prepared (available from authors). All analyses were carried 
out according to the principle of intention-to-treat (i.e. patients included according to their 
group allocation) and included only patients with observed baseline data (where required) and 
outcome data at follow-up. Where missing data was noted within an individual trial, contact with 
the author was attempted and data added if available, no missing data were imputed. Given the 
relatively small levels of missing outcome and covariate data within trials, we did not undertake data 
imputation. We checked for potential small study bias by assessing funnel plot asymmetry and using 
the Egger test35. 
 
Descriptive analysis 
 
The study-level and participant-level characteristics of included studies are presented in Table 1. Data 
from studies participating in the IPD analysis were compared with the data from those that opted not 
to participate to determine if the collective IPD cohort was a representative (unbiased) sample of the 
full set of existing studies. Independent t-tests were conducted for baseline characteristics in 
intervention versus control groups. A p value <0.01 was considered significant for all statistical 
analyses. 
 
IPD meta-analysis 
 
In this project we used both one-step and two-step IPD meta-analysis. 
 
One-step analysis 
For the one-step IPD analysis we fitted mixed effects models to the change in blood pressure (systolic, 
diastolic and mean arterial) with treatment as a fixed effect, treating each study as a random effect. 
This is the most logistically demanding, it accounts for the clusters generated by the different studies 
and allows for analysis of covariates and has the best performance in terms of power  25 . We 
repeated the analysis with the following moderating variables as factors: medication versus no 
medication, sex, age (under 45 years and 45 years and over), presence/absence of heart disease, 
BMI category (underweight 19 or under; normal >19 to 24.9; overweight (25.0-29.9); and obese 30 or 
over), bi-lateral vs uni-lateral IRT and arm versus leg IRT. That is, we assessed treatment by 
subgroup interaction effects (p-values) to determine whether the moderating variables influenced the 
treatment effect. All analyses followed the principle of intention-to-treat as closely as possible. 
Specifically, we included all studies that provided relevant outcome data. The one-step analyses were 
undertaken using R core team software, Vienna, Austria36. 
Subgroup and medication analysis 
We fitted mixed effects models to the change in blood pressure (systolic, diastolic and mean arterial) 
with study as random effect and treatment as well as the following moderating variables as factors; 
medication versus no medication, sex, age (under 45 years and 45 years and over), 
presence/absence of heart disease, BMI category (underweight 19 or under; normal >19 to 24.9; 
overweight (25.0-29.9); and obese 30 or over), bi-lateral vs uni-lateral IRT and arm versus leg IRT. 
We then conducted ANOVA tests to determine whether the moderating variables had a significant 
effect on the response to treatment. 
 
Regression Analyses 
Backward stepwise regression was employed to identify which clinical and study variables may best 
predict participants’ response to IRT. 
 
Two-step analysis 
The two-step analyses was conducted with each trial analysed using a random effects model for each 
outcome. A random effects model was preferred due to the high degree of clinical heterogeneity 
across the individual trials, which included different patient populations and comparators37. Analyses 
were completed for continuous data using the mean baseline-follow up change and change in 
standard deviation (SD) and the number of participants in each group, within or between group p 
values or 95% CI. Additionally, the I2 and τ2 statistics were reported alongside the associated p-value 
for the results of the main analyses. The two-step analyses were conducted using RevMan 5.3 (The 
Nordic Cochrane Centre, Copenhagen, Denmark). 
 
Data verification between included and excluded IPD data 
A comparison between the included studies and the studies that were excluded, as IPD data was not 
provided, was conducted for SBP and DBP analyses.   
 
Study Quality 
Study quality assessment of included studies was undertaken using the validated TESTEX scale 38. 
 
 
 
 
 
 
RESULTS: 
 
Search Results 
An initial search yielded 1386 potential articles. After duplicates were removed 952 article remained, 
909 were excluded based on title and abstract reviews, leaving 44 full text articles for evaluation. 
Acute studies accounted for 15 articles, 9 were not controlled trials and 3 did not utilize continuous 
isometric contractions. Six of the 18 eligible study authors were unable to provide the individual patient 
data as it had been destroyed or the relevant author could not be contacted/declined to participate 
(see Table 5 and Consort Statement in Supplementary Files). Twelve studies met the inclusion criteria 
and provided IPD data13,39-48 (Table 1) representing 326 participants, 191 assigned to IRT and 135 
controls. A summary of the baseline participant characteristics shows both the IRT and control groups 
to be similarly matched (Table 2). The MVC intensity in the IRT participants was 8% in 9 people, 10% 
in 11 people, 14% in 11 people, 18% in 10 people, 21% in 26 people and 30% in 124 people. None 
of the data were imputed, but Farah42 (n=46) provided no BMI data and Gordon 2017b45 (n=21) 
provided no medication data.  
 
Primary Analysis 
 
One-step analysis of variance showed that IRT treatment had a significant systolic blood pressure 
(SBP) lowering effect -6.22 mmHg mean difference (MD) (95% CI -7.75, -4.68; p<0.00001). Two 
step meta-analysis showed the mean difference in SBP to be MD -7.35 mmHg (-8.95, -5.75; 
p<0.00001), I2=22% (Figure 1). 
 Analysis of variance showed that IRT treatment had a significant mean diastolic blood pressure 
(DBP) -2.78 mmHg (95% CI -3.92, -1.65; p=0.002). The two-step approach yielded similar results 
for change in DBP MD -3.29 mmHg (95% CI -5.12, -1.46; p=0.0005), I2=63% (Figure 2). 
 
Analysis of variance showed that IRT treatment had a significant mean arterial blood pressure 
(MAP) IRT -4.12 mmHg (95% CI -5.39, -2.85; p<0.0001). The two-step approach yielded similar 
results for change in MAP MD -4.63 mmHg (95% CI -6.18, -3.09: p<0.00001); I2 =47% (Figure 3). 
 
These results are summarized in Table 3.  
 
One-step versus two-step model comparison. 
A comparison of the change in blood pressures between the one-step and two-step models 
revealed that both analyses resulted in statistically significant outcomes for SBP, DBP and MAP. 
Furthermore the mean difference values varied by only 1.2 mmHg for SBP, 0.51 mmHg for DBP 
and 0.51 mmHg for MAP, with the two-step model always producing the greater reductions in all 
three blood pressure measurements, see Table 3. 
 
Included versus missing or excluded trial data. 
A comparison of the 12 included, and 6 excluded, randomized, controlled trials was made using a 
two-step (group-level) meta-analysis. This analysis showed that, for the 6 excluded studies, the 
statistical significance of SBP was MD -5.61 mmHg (-9.04, -2.19) p=0.001; DBP MD -4.27 mmHg (-
7.92, -0.62) p=0.02; MAP MD-1.92 (-3.00, -0.84) p=0.0005. These values were within 0.61 mmHg of 
the corresponding value for the 12 included studies for the one-step model equivalents for SBP, and 
within 1.49 mmHg for DBP, while the MAP showed a 1.37 mmHg difference. The summary statistics 
of these comparisons are in Table 3, while the forest plots are in supplementary files. 
 
Secondary Analyses 
We then conducted sub-analyses based upon the significant findings in SBP, DBP and MAP. We did 
not detect any significant effects (even if p<0.05 rather than our stipulated p<0.01 was used) of sex, 
medication status, BMI category (underweight, normal, overweight and obese), age (45 years and 
over versus under 45 years), hypertensive status (normotensive versus hypertensive), bi-lateral vs 
uni-lateral IRT and arm versus leg IRT on the treatment effect. Furthermore, there were insufficient 
studies with coronary heart disease participants to justify an analysis on the IRT treatment effect.  
Backward stepwise regression was employed to identify which participants may best respond to IRT. 
These regression analyses failed to identify a model formed from any clinical or program variables 
that significantly predicted blood pressure response to isometric resistance training. 
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 Sex 
Eight studies had male and female participants with one study having one female only. There was 
no evidence of an effect of sex on the treatment response for SBP, DBP and MAP. 
 
Anti-hypertensive Medication Status 
Five studies had both medicated and unmedicated patients. There was no evidence of a medication 
effect for change in SBP, DBP and MAP. Neither adherence to medication nor changes were 
recorded in any study, although unmedicated participants who undertook IRT showed a trend 
towards a greater reduction in SBP than their medicated counterparts; MD -10.18 mmHg (-15.50, -
4.86) medicated versus – 5.86 mmHg (-9.19, -2.54) un-medicated. 
 
Body Mass Index 
All studies reported BMI class, there was little evidence of an effect of BMI class on size of change 
in SBP, DBP and MAP.  
 
Age 
Seven studies had patients both under and over 45 years of age groups, there was no evidence of 
an effect of age on size of change in SBP, DBP and MAP.  
 
Hypertensive Status 
Four studies had both normotensive and hypertensive patients, there was no evidence that blood 
pressure status had an effect on the size of change in SBP, DBP and MAP.  
 
Unilateral versus Bilateral Isometric Exercise 
There was no evidence (see Table 1) that unilateral (n=52 exercise participants from 4 studies) or 
bilateral IRT (n=139 exercise participants from 8 studies) had an effect on the size of change in 
SBP, DBP and MAP.  
 
Arm versus lower Limb Isometric Exercise 
There was no evidence (See Table 1) that arm (n=197 exercise participants from 6 studies) or leg 
IRT (n=129 exercise participants from 6 studies) had an effect on the size of change in SBP, DBP 
and MAP.  
 
Study Design Variables 
There were no significant differences observed for comparisons of any of the study design variables; 
uni- versus bi-lateral exercise, arm vs leg, outpatient vs home, office vs ambulatory blood pressure 
measurement. We did not conduct an analysis of exercise specialists vs non-exercise specialist 
supervision as so few studies/patients were supervised by an exercise specialist. 
 
Disease Status 
There were insufficient people with coronary heart disease to draw meaningful conclusions from this 
analysis.  
 
Risk of Bias 
Funnel plots revealed some risk of publication bias, which is not surprising as we are aware of 6 
published datasets from which individual patient data were not available.  
 
Study Quality 
A summary of study quality assessment of included studies, utilising the TESTEX Scale49 can be 
seen in Table 4. Four studies scored 9, 7 studies scored 10 and one study scored 11 out of 15, 
median score was 10. 
 
 
Post-Hoc Sample Size Estimate 
 
Based upon the results of our one-step model SBP analysis -6.22mmHg 95% C.I. (-7.75, -4.68 
mmHg) we calculate that the minimum sample size required to detect this magnitude of SBP 
change, with 90% power would be approximately 60 participants in each group, if one were to factor 
in 10% attrition then this number would rise to 66 per group. 
 
 
 
 
 
 
 
DISCUSSION 
 
The findings of the present IPD meta-analysis support the capacity for IRT to reduce resting blood 
pressure, specifically SBP, DBP and MAP. The one-step and two-step analyses were very similar for 
SBP and DBP whilst there was only a difference of about 2.5mmHg for the MAP analysis. These 
values are also in agreement with those reported in previous ‘aggregated data’ meta-analyses 8,15,17. 
These results offer new insights into the scope of participants that will reap the benefit following IRT. 
Taken together, this work supports the use of IRT as a novel non-pharmacologic therapy to manage 
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high blood pressure in selected patients, in line with current recommendations6 and support future 
trials to identify the patients most likely to respond to IRT 11,50. 
 
We found no evidence that sex had an effect on the treatment response for SBP, DBP and MAP. 
Conflicting information from previous work has suggested that both men15 and women51 may have 
greatest potential to reduce blood pressure. Yet other work has suggested that men and women 
have the potential to reduce blood pressure using IRT by a similar magnitude52, this is consistent 
with our analysis. 
 
Our analyses showed unmedicated participants who undertook IRT had a trend towards a greater 
reduction in SBP than their medicated counterparts. Previous work has suggested that medication 
use may blunt the anti-hypertensive effects of IRT14, possibly due to a shared mechanism.  
 
Our analysis did not suggest a trend towards a greater change in SBP with changing BMI 
classification. There was also no evidence of an effect of age on size of change in SBP, DBP and 
MAP. The age cut-off for this analysis, of 45 years, is somewhat arbitrary but does reflect similarity 
with previous analyses that have examined if the size of blood pressure reductions vary between 
older and younger participants15. All of these sub-analyses were likely to be underpowered to detect 
change in sex, medication status, BMI classification or age. 
 
Our IPD meta-analysis represents the first time that it has been possible to investigate the potential 
interaction of specific anti-hypertensive pharmacological classes on the blood pressure response to 
IRT, as insufficient data existed previously to conduct meaningful analyses. It has been hypothesized 
that medicated hypertensive participants might not respond to IRT at the same rate as un-medicated 
participants due to the potential mechanistic overlap of anti-hypertensive medications 14. The results 
from this analysis suggest that individuals who use blood pressure lowering medications may exhibit 
similar anti-hypertensive response to IRT-based interventions. Moreover, the size of blood pressure 
reduction observed in this IRT IPD are superior to those observed from aerobic exercise, in a previous 
meta-analysis53.  
 
IRT anti-hypertensive effects 
The mechanisms responsible for the reduction in resting blood pressure after IRT are unclear 14. 
Research has supported a role of IRT to increase endothelial-dependent vasodilation, a marker of 
nitric oxide bioavailability 27,51,52. This would suggest that IRT may lower blood pressure by reducing 
total peripheral resistance, similar to dynamic aerobic exercise 8. The absence of statistically 
significant evidence of a relationship with specific classes of anti-hypertensive medications is an 
important finding for helping to identify participants most likely to respond to IRT. This finding also 
supports studies exploring the use of this type of exercise as an adjunct to existing anti-hypertensive 
treatment 40.  Previous work on the anti-hypertensive effects of aerobic exercise training has 
postulated that 12 weeks exposure may lead to enhanced vasodilation and reduced vascular 
resistance54,55, however only two IRT studies have been of 12 weeks duration.  
 
The convenience and practicality of employing IRT as a treatment tool are advantageous. IRT 
exercise can be implemented while seated, at any time of the day, and is easily accessible for most 
patients with mobility issues. A drawback of IRT is that the benefits to date have been confined to 
blood pressure, unlike dynamic aerobic exercise which impacts a number of other cardiovascular risk 
factors (e.g. body weight, insulin resistance, HDL cholesterol)56. Nevertheless, IRT may offer a novel 
non-pharmacologic lifestyle option for treating hypertension. Our results question previous work that 
identified key variables, such as sex and age, as barriers to acquiring anti-hypertensive effects from 
IRT-based interventions. It is also important to consider that blood pressure reductions can reduce 
the risk of myocardial infarction, transient ischemic attack, CAD, and mortality 57. The ever-increasing 
evidence for IRT warrants larger scale RCT studies to further support its efficacy.  
 
 
Limitations 
 
As with most IRT research, the available sample size remains small compared to work in aerobic 
exercise training 8,56. We recognize that the results are based on efficacy studies, conducted under 
optimal conditions compared to "real world" settings. As such the generalizability of our results are 
limited as they are based on studies in restricted samples of volunteers.  
A number of participants were using anti-hypertensive medications during the course of this study. 
However, there were only a small number of participants that were using multiple anti-hypertensive 
medications.  There were insufficient numbers of participants taking the various classes of anti-
hypertensive medications to allow analyses between the different agents. No adherence to 
medication or changes were recorded in any study and small numbers of participants taking some 
medications precluded an analysis of any specific drug and IRT interaction effects. 
 
Insufficient numbers of people in each of the various BMI (underweight, normal, overweight and 
obese) categories may have meant these sub-analyses were underpowered to show significant 
improvements in systolic, diastolic and mean arterial pressure. There were some missing BMI data 
from Farah42 (n=46) and Gordon 2017b45 (n=21) provided no medication data. Considering that 
these sub-analyses were quite some way from reaching statistical significance the missing data 
could not have altered the findings. 
 
The studies by Stiller-Moldovan12, Goessler43, Farah42 and the recent work by Taylor et al.58 are the 
only randomized trials to date to report both clinic and ambulatory BP measurements. Ambulatory 
measurements, especially nighttime measurements, provide a better approach the risk estimation 
compared to office measurements and until ambulatory findings have been confirmed in a larger study 
population, the true value of IRT as a therapy for hypertension will remain unclear. 
 
Enrolment in trials of behavioural modification in high blood pressure is known to raise subject 
awareness of interventions such as medication, weight loss, dietary sodium reduction etc. That said, 
these data were not reported, so we did not record any change in pre- and post-study body weights, 
or medication dosage or adherence, so we cannot rule out concomitant weight loss and changes in 
medication use as confounding factors. 
 
These findings have implications for future research designs as contrary to pre-existing arguments, 
there is no evidence that specific participant characteristics are more or less likely to derive optimal 
benefit from IRT and therefore most people could expect to benefit from an anti-hypertensive effect 
of this treatment. 
 
CONCLUSIONS 
 
Inadequate blood pressure control puts millions of people around the world at risk of the potentially 
fatal consequences of hypertension. This IPD analysis confirms a clinically meaningful and 
statistically significant effect of IRT on resting blood pressure. Future prospective clinical trials are 
needed to confirm the effectiveness of IRT as a non-pharmacologic therapy to treat hypertension.  
 
By demonstrating for the first time, using our robust IPD design, the effectiveness of IRT to lower 
blood pressure in high risk hypertensive populations, we provide much needed support for its 
potential adoption as part of hypertension standard of care treatment.  
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List of Tables 
Table 1. Studies included in this analysis examining the effects of isometric exercise training on blood pressure. 
REFERENCE (YEAR) STUDY DESIGN PARTICIPANTS EXERCISE MODE & INTENSITY  MAJOR FINDINGS  
       (n) 
Badrov et al., 2013  RCT   Ex: 12   Alternating Bilateral IHG.   SBP 8mmHg, DBP 5mmHg 
    Medicated  Con: 12   4x2min, 1 min rest periods   MAP 6mmHg, DBP 4mmHg 
    Hypertensive  13Males, 11Females 30% MVC; 3 times a week for 
       Age 51-74 yrs for 10 weeks  
 
Baross et al., 2012  RCT   Ex: 10 (14%)  Bilateral leg extension;   SBP 11mmHg, MAP 5.0mmHg 
       Ex: 10 (8%)  ~14% & ~8% MVC    HR 4.8, ↓ (14% MVC)  
Pre-hypertensive Con: 10 (20M) 4x2 min, 2-min rest periods   Resting BP No Change (8% MVC) 
    & hypertensive 20 Males  8 weeks   
       Age 45-60 
 
Baross et al. 2013  RCT   Ex:10   Bilateral leg extensions at 18% MVC; SBP 10.8mmHg, MAP 4.7mmHg 
Con: 10  4x2 min, 2-min rest periods   HR 4.8 beats/min 
       20 Males  thrice weekly for 8 weeks 
       Age 45-60 yrs 
 
Carlson et al. 2016  RCT   Ex: 20   Unilateral IHG, 4x2min, 3 min    5% SBP 2mmHg, DBP 3mmHg 
    Pre-hypertensive   Con: 20  rest periods at 5% (n=20) or 30%  MAP 3mmHg, HR 1mmHg 
& hypertensive  15 Male, 25 Female (n=20) MVC, 3 times a week for  30% SBP 7mmHg, DBP 2mmHg 
Age 36-65  8 weeks                MAP 4mmHg, HR 2mmHg 
 
Farah 2018   RCT   Ex: 30   Alternate Unilateral, IHG, 4x2 min  30% SBP 11mmHg,  
    Hypertensive  Con: 16  30% MVC; 1-min rest; thrice weekly; DBP 6mmHg 
       14 Male, 32 Female for 12 weeks 
Age 38-79 yrs  
        
 
Goessler et al. 2018  RCT   Ex: 19   Daily 4x2 mins, 1min rest   30% SBP 4.4mmHg,  
    Healthy  Con: 14  Bilateral handgrips 30 %MVC for 8 weeks DBP 3.3mmHg 
       30-36 yrs 
       15 Males, 18 Females 
       Age 21-59yrs 
 
Gordon et al. 2017a  RCT Outpatient Ex. 6   Unilateral IHG, 4x2-min at 30% MVC 30% No Change SBP, DBP 
    Cardiopulmonary Con 5   1-min rest for 6-weeks 
    Medicated  10Males, 1 Female 
    Hypertensive  Age 50-80 
        
Gordon et al. 2017b  RCT   Home(n=9)  Unilateral;  
    Hypertensive  Lab (n=7)  IHG 30%MVC     30% Lab SBP 9.0 mmHg  
       Con (n=5)  MVC 30%; 4x2 min; 1-min rest  Home 30% 8.6mmHg SBP 
       6 Males, 15 Females for 12 weeks  
       Age 24-60yrs  
 
Hess et al. 2016  RCT   Ex:10   Unilateral IHG, 4x2min, 3 min,  10% SBP 5.6mmHg,  
Healthy  Con:10  10% MVC and 5% MVC (control)  DBP1.8mmHg 
13Males, 7Females 1-min rest; 8 weeks 
       Age 26-50 yrs 
       
Stiller-Moldovan et al., RCT   Ex: 11   Alternating Bilateral IHG   No change resting or 24 hour  
2012    Medicated  Con: 9   4x2min, 1 min rest periods   ambulatory BP 
    Hypertensive  10Males, 10Females 8 weeks, 30% MVC. 3 times a week for 
       Age 42-76 
 
Wiles et al., 2010  RCT   Ex: 22   Bilateral leg extension   SBP 3.7mmHg in LI 
    Normotensive Con: 11  4x2min, 2 min rest periods   SBP 5.2mmHg in HI 
       33Males  3 days a week for 8 weeks   DBP 2.6mmHg in both 
       Age 18-34  10% & 21% MVC     MAP 2.5 LI & 2.6 HI 
            
Wiles et al 2017  Randomized  Ex :15   Wall Squat @95% Max HR   21% SBP 4.2mmHg,  
    Crossover  Con:13  ~21%MVC, 4x2min, 2 min rest periods  DBP2.8mmHg MAP 3.0mmHg 
    Normotensive 28 Males  3 days/week for 4 weeks 
       Age 30±7 yrs 
All blood pressure readings are reported as means. 
BA= Brachial Artery, Con=Control, DBP=Diastolic Blood Pressure, Ex= Exercise, FMD= Flow Mediated Dilation,  HI=High Intensity, HR=Heart Rate,  IHG= Isometric Hand Grip, LI=Low intensity,  MAP= Mean Arterial Pressure, 
MVC=Maximum Voluntary Contraction, n=Number of participants PP= Pulse pressure, RCT= Randomized Control Trial, SBP= Systolic Blood Pressure 
indicates reduction,  indicates no change, indicates increase. 
 
 
Table 2. Summary of baseline characteristics of the study participants included in the individual participant data meta-analysis. 
     
Demographic All (n=326) Exercise (n=191) Control (n=135) 
Age * 48.58, 16.33, 18/80 48.2, 16.4, 18/78 49.1, 16.3, 18/80 
Male ** 205 120 (59%) 85 (41%) 
BMI mean* 28.31, 
5.73,18.23/58.06 
28.4, 5.25, 18.9/51 28.1, 6.37, 18.2/58.1 
Hypertension ** 109 63 (58%) 46 (42%) 
Blood Pressure    
Systolic (mmHg) * 129.54, 15.18, 
90.5/188 
130., 14.7, 95/188 128., 15.8, 90.5/167 
Diastolic (mmHg) * 76.19, 10.12, 45/105 77.0, 9.52, 54.3/105 75.1, 10.9, 45/99 
Mean Arterial (mmHg) * 94.31, 10.50, 
62.22/131 
95.1, 9.77, 71.7/131 93.2, 11.4, 62.2/119 
Medications***    
ACE Inhibitor 58  33 (57%) 25 (43%) 
Beta Blocker 33 21 (64%) 12 (36%) 
Calcium Channel Blocker 37 22 (59%) 15 (41%) 
Diuretic 61 39 (64%) 22 (36%) 
ARB II Antagonist 67 38 (57%) 29 (43%) 
 
* reporting mean, SD, min/max 
** reporting totals and percentages for the exercise and control groups 
*** reporting totals and percentages for the exercise and control groups without Gordon et al. 2017b, as the data do not show type of 
medication for this study 
 
 
 
 
 
 
 
Table 3. Baseline versus post-intervention changes in blood pressure for IRT v control participants included in the individual participant data meta-
analysis. One- and two-step model analyses. 
One-Step Model Exercise  
MD mmHg (95%CI) 
 
Control 
MD mmHg (95%CI) 
p treatment effect 
∆ SBP -6.22 (-7.75, -4.68)  -0.14 (-1.93, 1.65) <0.00001 
∆ DBP  -2.78  (-3.92, -1.65)  -0.45 (-1.76, 0.85) 0.002 
∆ MAP  -4.12 (-5.39, -2.85)  -0.32 (-1.76, 1.13) <0.00001 
 
Two-Step Model n=12 
Included Studies 
Exercise vs Control 
MD mmHg (95%CI) 
Exercise vs Control 
MD mmHg (95%CI) 
 
p treatment effect  
∆ SBP -7.32 (-8.93, -5.71); I2=22% <0.00001 
∆ DBP -3.29 (-5.12, =1.46); I2=63% 0.0004 
∆ MAP -4.63 (-6.18, -3.09); I2=47% <0.00001 
Two-Step Model n=6 
Excluded Studies 
Exercise vs Control 
MD mmHg (95%CI) 
p treatment effect 
∆ SBP -5.61 (-9.04, -2.19); I2=82% 0.001 
∆ DBP -4.27 (-7.92, -0.62); I2=91% 0.02 
∆ MAP -1.92 (-3.00, -0.84); I2=7% 0.0005 
 
 
 
 
 
 
 
 
 
 
Table 4. Study Quality Assessment of Included Studies (using TESTEX Scale). 
Study name 
Eligibility 
Criteria 
specified 
Randomly 
allocated 
participants 
Allocation 
concealed 
Groups 
Similar at 
baseline 
Assessors 
blinded 
Outcome 
Measures 
assessed >85% 
of participants# 
Intention 
to treat 
analysis 
Reporting of 
between 
group 
statistical 
comparisons 
Point 
measures 
& measures 
of variability 
reported*  
 
Activity 
Monitoring 
in Control 
Group 
 
Relative 
Exercise 
Intensity 
Review 
 
Exercise 
Volume & 
Energy 
Expended 
Overall 
TESTEx 
Badrov (2013) YES YES Unclear YES NO YES (2) NO YES YES (2) NO YES NO 9 
Baross (2013) YES YES Unclear YES NO YES (2) YES YES YES (2) NO YES NO 10 
Baross (2012) YES YES Unclear YES NO YES (2) YES YES YES (2) NO YES NO 10 
Carlson (2017) YES YES YES YES NO YES(2) YES YES YES (2) NO YES NO 11 
Farah (2018) YES YES NO YES NO YES (2) YES YES YES (2) NO YES NO 10 
Goessler (2018) YES YES NO YES NO YES (2) YES YES YES (2) NO YES NO 10 
Gordon (2017a) YES YES NO YES NO YES (2) Unclear YES YES (2) NO YES NO 9 
Gordon (2017b) YES YES NO YES NO YES (2) Unclear YES YES (2) NO YES NO 9 
Hess (2016) YES YES NO YES NO YES (2) YES YES YES (2) NO YES NO 10 
Stiller-Moldovan 2012 YES YES Unclear YES NO YES (2) NO YES YES (2) NO YES BO 9 
Wiles (2010) YES YES NO YES NO YES (2) YES YES YES (2) NO YES NO 10 
Wiles (2017) YES YES NO YES NO YES (2) YES YES YES (2) NO YES NO 10 
 
Total out of 15 Points 
Legend:  # Three points possible – 1 point if adherence>85%, 1 point if adverse vents reported, 1 point if exercise attendance is reported 
   *Two points possible – 1 point if primary outcome is reported, 1 point if all other outcomes reported 
   NR – not reported 
 
 
 
 
 
 
 
 
 
 
 
Table 5. Randomized, Controlled Trials not Included in this Meta-Analysis. 
Eligible Studies Unable to Provide Individual Patient Data 
Devereux 2011 – Data destroyed due to time elapsed 
Gill 2015 – Data lost 
Millar 2008 – Data destroyed due to time elapsed 
Pagonas 2016 – Refused to participate 
Taylor 2003 – Data destroyed due to time elapsed 
Wiley 1992 – Unable to contact author  
Non-Eligible RCTs Reason for Exclusion 
Ash 2017 Sub-set analysis of larger trial 
 
